trending Market Intelligence /marketintelligence/en/news-insights/trending/ia5bael96nsmss1clileyq2 content esgSubNav
In This List

BioDelivery Sciences to raise $50M in equity financing

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

BioDelivery Sciences to raise $50M in equity financing

BioDelivery Sciences International Inc. is looking to raise about $50 million via the sale of preferred stock.

The series B stock, priced at $10,000 each, will be convertible into common shares of the company at $1.80 apiece.

The transaction is expected to close May 21 with William Blair & Co. LLC acting as the sole placement agent in the offering.

Raleigh, N.C.-based BioDelivery Sciences develops and commercializes pharmaceutical products mainly for pain management and addiction.